All the OS markers of the CRC patients presented significant differences during the follow-up with respect to controls, especially at baseline and at 1 and 6 months (p < 0.001); at 12 months the differences were less significant for CAT, GSSG and GSSG/GSH (p < 0.05) (Fig. 4). The gene discussed is CAT; the disease is colorectal carcinoma.